Skip to main content
Back to News
DP Technology has secured 800 million yuan (US$114 million) in Series C funding to scale its AI-for-...
Funding
1 min read
CN

DP Technology has secured 800 million yuan (US$114 million) in Series C funding to scale its AI-for-...

The AMW Read

Updates the player map for the AI-for-Science vertical with a significant Series C round for DP Technology's molecular simulation tools.
NoveltySignificance
Healthcare & Bio ยท Player Map

DP Technology has secured 800 million yuan (US$114 million) in Series C funding to scale its AI-for-Science infrastructure. The firm uses tools like SciMaster and Piloteye to automate molecular simulations for battery and drug design. This investment marks a transition where AI becomes a foundational operating system for material and life sciences. By digitizing physics via the Particle Universe model, researchers are bypassing trial-and-error bottlenecks at an industrial scale. This shift will permanently accelerate global scientific discovery. ๐Ÿš€๐Ÿงช๐Ÿ”‹

#AI #DeepTech #Science #Innovation #Funding

How This Connects

Based on Healthcare & Bio ยท Player Map

  1. 1d agoMoleculeOS launches as AI operating system for biology R&D, signaling platform shift in drug discoveryMoleculeOS
  2. 1w agoAnthropic releases Claude Science Beta, a multi-agent AI workbench designed to run end-to-end resear...Anthropic
  3. 1w agoBaiyao Tech (็™พๆ›œ็ง‘ๆŠ€) releases AURA CellOS, first AI virtual cell based on LLM-JEPA architecture.็™พๆ›œ็ง‘ๆŠ€
  4. 1w agoAnthropic launches Claude Science AI workbench for life sciences researchAnthropic
  5. 6mo agoDP Technology has secured 800 million yuan (US$114 million) in Series C funding to scale its AI-for-... ยท THIS ARTICLE

Related News

More news from DP Technology

Stay updated with the latest news and announcements from DP Technology.

View all DP Technology news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard